Discussion The present study showed an increasing trend of PDR to efavirenz in Mexico City from 2017 to 2020, crossing the 10% threshold by the end of the study period, while PDR to dolutegravir and bictegravir remained low and under 0.5%.
1
—
—
Discussion The present study showed an increasing trend of PDR to efavirenz in Mexico City from 2017 to 2020, crossing the 10% threshold by the end of the study period, while PDR to dolutegravir and bictegravir remained low and under 0.5%.